Nucleic acid testing of sars‐cov‐2

55Citations
Citations of this article
115Readers
Mendeley users who have this article in their library.

Abstract

The coronavirus disease 2019 (COVID‐19) has caused a large global outbreak. It is accordingly important to develop accurate and rapid diagnostic methods. The polymerase chain reaction (PCR)‐based method including reverse transcription‐polymerase chain reaction (RT‐PCR) is the most widely used assay for the detection of SARS‐CoV‐2 RNA. Along with the RT‐PCR method, digital PCR has emerged as a powerful tool to quantify nucleic acid of the virus with high accuracy and sensitivity. Non‐PCR based techniques such as reverse transcription loop‐mediated isothermal amplification (RT‐LAMP) and reverse transcription recombinase polymerase amplification (RT‐ RPA) are considered to be rapid and simple nucleic acid detection methods and were reviewed in this paper. Non‐conventional molecular diagnostic methods including next‐generation sequencing (NGS), CRISPR‐based assays and nanotechnology are improving the accuracy and sensitivity of COVID‐19 diagnosis. In this review, we also focus on standardization of SARS‐CoV‐2 nucleic acid testing and the activity of the National Metrology Institutes (NMIs) and highlight resources such as reference materials (RM) that provide the values of specified properties. Finally, we summarize the useful resources for convenient COVID‐19 molecular diagnostics.

Cite

CITATION STYLE

APA

Yoo, H. M., Kim, I. H., & Kim, S. (2021, June 1). Nucleic acid testing of sars‐cov‐2. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms22116150

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free